Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country

about

Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country

Item

http://www.wikidata.org/entity/Q56910734

description

article

@en

im August 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country

@en

Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country

@nl

type

Item

label

Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country

@en

Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country

@nl

prefLabel

Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country

@en

Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country

@nl

P1476

Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country

@en

P2093

Catherine Regan

http://www.w3.org/2001/XMLSchema#string

Emily A Burger

http://www.w3.org/2001/XMLSchema#string

Jane J Kim

http://www.w3.org/2001/XMLSchema#string

Nicole G Campos

http://www.w3.org/2001/XMLSchema#string

Stephen Sy

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials.

A multicountry evaluation of careHPV testing, visual inspection with acetic acid, and papanicolaou testing for the detection of cervical cancer.

An updated natural history model of cervical cancer: derivation of model parameters.

Health and economic implications of HPV vaccination in the United States.

Comparison of two dose and three dose human papillomavirus vaccine schedules: cost effectiveness analysis based on transmission model

Thresholds for the cost-effectiveness of interventions: alternative approaches.

Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica.

Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study.

Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study.

Cancer survival in Africa, Asia, and Central America: a population-based study.

P304

4823-4829

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VACCINE.2018.04.061

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

32 Pt A

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-08-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29807710

http://www.w3.org/2001/XMLSchema#string

P921

infectious disease

molecular medicine

P932

6066173

http://www.w3.org/2001/XMLSchema#string